Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Anniston, AL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
El Cajon, CA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Laguna Hills, CA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
San Francisco, CA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Aurora, CO
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Gainesville, FL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Jupiter, FL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Orlando, FL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Chicago, IL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
College Park, MD
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
College Park, MD
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Elkridge, MD
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Elkridge, MD
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Boston, MA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Omaha, NE
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
High Point, NC
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Athens, OH
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Athens, OH
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Columbus, OH
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Spartanburg, SC
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Richmond, VA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
South Miami, FL
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Edina, MN
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Duncansville, PA
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Plano, TX
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
Clinical Research Facility
mi
from
West Jordan, UT
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated:  2/29/2016
mi
from
Limoges,
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia
Status: Enrolling
Updated: 2/29/2016
mi
from
Limoges,
Click here to add this to my saved trials
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated:  2/29/2016
Indiana University
mi
from
Indianapolis, IN
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated: 2/29/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Cypress, CA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Stanford, CA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Boston, MA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Durham, NC
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction
Status: Enrolling
Updated:  3/1/2016
University of Virginia Health System
mi
from
Charlottesville, VA
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction
Status: Enrolling
Updated: 3/1/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
Status: Enrolling
Updated:  3/2/2016
Private Practice of Dr. Andrew Blitzer
mi
from
New York, NY
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
Status: Enrolling
Updated: 3/2/2016
Private Practice of Dr. Andrew Blitzer
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Thiazolidinediones on Human Bone
Effects of Thiazolidinediones on Human Bone Marrow Stromal Cell Differentiation Capacity:In Vitro and In Vivo- A Pilot Study
Status: Enrolling
Updated:  3/2/2016
Grady Diabetes Clinic
mi
from
Atlanta, GA
Effect of Thiazolidinediones on Human Bone
Effects of Thiazolidinediones on Human Bone Marrow Stromal Cell Differentiation Capacity:In Vitro and In Vivo- A Pilot Study
Status: Enrolling
Updated: 3/2/2016
Grady Diabetes Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures Requiring Extensile Lateral Incision
Status: Enrolling
Updated:  3/2/2016
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures Requiring Extensile Lateral Incision
Status: Enrolling
Updated: 3/2/2016
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated:  3/2/2016
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated: 3/2/2016
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
Click here to add this to my saved trials
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated:  3/2/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated: 3/2/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated:  3/2/2016
The Center for Pain Relief
mi
from
Charleston, WV
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects
Status: Enrolling
Updated: 3/2/2016
The Center for Pain Relief
mi
from
Charleston, WV
Click here to add this to my saved trials
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated:  3/3/2016
Emory University
mi
from
Atlanta, GA
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated: 3/3/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials